Efficacy and Safety Study of Ketorolac / Pitofenone / Fenpiverinium for the Treatment of Patients With Pain After Surgical Abdominal and Pelvic Operations
Clinical trial NCT05607641 · COMPLETED
Trial details
- NCT number
- NCT05607641
- Sponsor
- Darnitsa Pharmaceutical Company
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-07
- Primary completion
- 2022-05-07
- Enrollment
- 424
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.